Related Experiment Videos
Secretion of genetically engineered human/mouse class I antigens.
N Cohen1, J S Crawford, D D Hiraki
1Department of Pathology, Stanford University School of Medicine, California.
Human Immunology
|July 1, 1989
Summary
Researchers engineered two soluble HLA-B7 forms using human/mouse gene hybrids. These soluble HLA-B7 molecules, crucial for structural and functional studies, were successfully secreted and characterized.
Area of Science:
- Immunogenetics
- Molecular Biology
- Protein Engineering
Background:
- Human Leukocyte Antigen (HLA) class I molecules play critical roles in immune responses.
- Engineering soluble forms of HLA molecules is essential for detailed structural and functional analysis.
- Previous studies have explored hybrid molecules for functional characterization.
Purpose of the Study:
- To engineer and characterize two novel soluble, secreted forms of HLA-B7.
- To investigate the role of specific domains in the secretion of hybrid HLA class I molecules.
- To facilitate large-scale production of soluble HLA-B7 for further research.
Main Methods:
- Creation of hybrid human/mouse genes combining HLA-B7 and mouse Q10d sequences.
- Engineering of two constructs (F1 and C2) with varying human and mouse domains.
- Gene transfection into the J27.2 cell line for protein expression.
- Characterization of secreted proteins using monoclonal antibodies.
Main Results:
- Successfully engineered two soluble HLA-B7 hybrid molecules (F1 and C2).
- Demonstrated secretion of the F1 construct, indicating the Q10 alpha 3 domain is not essential for secretion.
- Both soluble forms were recognized by several monoclonal antibodies, with differential recognition by one antibody (Q1/28).
Conclusions:
- The engineered soluble HLA-B7 forms can be effectively produced and secreted.
- The study provides insights into the structural requirements for secretion of hybrid class I molecules.
- These soluble molecules are valuable tools for future structural and functional investigations of HLA-B7.